OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX

OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX

Bibliographic Details
Main Authors: K. Lima, H.P. Vicari, C. Hirakata, J.A.E.G. Carlos, J.C.L. Silva, F. Traina, L.L.F. Pontes, L.V. Costa-Lotufo, E.M. Rego, J.A. Machado-Neto
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920305757
id doaj-8de545b319ce4d79862bde0f305793dc
record_format Article
spelling doaj-8de545b319ce4d79862bde0f305793dc2020-11-25T04:00:56ZengElsevierHematology, Transfusion and Cell Therapy2531-13792020-11-0142172OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAXK. Lima0H.P. Vicari1C. Hirakata2J.A.E.G. Carlos3J.C.L. Silva4F. Traina5L.L.F. Pontes6L.V. Costa-Lotufo7E.M. Rego8J.A. Machado-Neto9Departamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, Brazil; Laboratório de Investigação Médica em Hematologia Molecular (LIM-31), Departamento de Hematologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP),São Paulo, SP, BrazilDepartamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, BrazilDepartamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, BrazilDepartamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, BrazilDepartamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, BrazilDepartamento de Imagens Médicas, Hematologia e Oncologia Clínica, Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, BrazilDepartamento de Imagens Médicas, Hematologia e Oncologia Clínica, Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, BrazilDepartamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, BrazilLaboratório de Investigação Médica em Hematologia Molecular (LIM-31), Departamento de Hematologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP),São Paulo, SP, BrazilDepartamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, SP, Brazilhttp://www.sciencedirect.com/science/article/pii/S2531137920305757
collection DOAJ
language English
format Article
sources DOAJ
author K. Lima
H.P. Vicari
C. Hirakata
J.A.E.G. Carlos
J.C.L. Silva
F. Traina
L.L.F. Pontes
L.V. Costa-Lotufo
E.M. Rego
J.A. Machado-Neto
spellingShingle K. Lima
H.P. Vicari
C. Hirakata
J.A.E.G. Carlos
J.C.L. Silva
F. Traina
L.L.F. Pontes
L.V. Costa-Lotufo
E.M. Rego
J.A. Machado-Neto
OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX
Hematology, Transfusion and Cell Therapy
author_facet K. Lima
H.P. Vicari
C. Hirakata
J.A.E.G. Carlos
J.C.L. Silva
F. Traina
L.L.F. Pontes
L.V. Costa-Lotufo
E.M. Rego
J.A. Machado-Neto
author_sort K. Lima
title OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX
title_short OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX
title_full OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX
title_fullStr OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX
title_full_unstemmed OBATOCLAX REDUCES CELL VIABILITY OF ACUTE MYELOID LEUKEMIA CELLS INDEPENDENTLY OF THEIR SENSITIVITY TO VENETOCLAX
title_sort obatoclax reduces cell viability of acute myeloid leukemia cells independently of their sensitivity to venetoclax
publisher Elsevier
series Hematology, Transfusion and Cell Therapy
issn 2531-1379
publishDate 2020-11-01
url http://www.sciencedirect.com/science/article/pii/S2531137920305757
work_keys_str_mv AT klima obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT hpvicari obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT chirakata obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT jaegcarlos obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT jclsilva obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT ftraina obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT llfpontes obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT lvcostalotufo obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT emrego obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
AT jamachadoneto obatoclaxreducescellviabilityofacutemyeloidleukemiacellsindependentlyoftheirsensitivitytovenetoclax
_version_ 1724448382604279808

Similar Items